Zeldin Robert K 4

What Happened

• Robert K. Zeldin, Chief Medical Officer of MeiraGTx Holdings plc (MGTX), received an award of 100,000 restricted share units (RSUs) on 2026-06-25. The RSUs were granted at $0.00 (no cash paid) and are derivative awards that convert into ordinary shares upon vesting.

Key Details

• Transaction date: 2026-06-25; Form 4 filed: 2026-06-29 (timely filing).
• Transaction type: Award/Grant (Code A); 100,000 RSUs granted at $0.00.
• Conversion: Each restricted share unit converts into one ordinary share upon vesting (per footnote).
• Vesting schedule: 50% vests on the 2nd anniversary of the grant; 25% vests on each of the 3rd and 4th anniversaries.
• Shares owned after transaction: Not specified in the provided filing.
• No indication of sale or immediate share disposition—this is a time‑based compensation award, not an open‑market purchase or sale.

Context

• RSU grants are common forms of executive compensation and represent potential future ownership if vesting conditions are met; they do not reflect an immediate cash purchase or sale. This grant increases potential future insider ownership subject to the listed vesting schedule.